US FDA demystifies good laboratory practice rules for medtech
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued draft guidance designed to answer commonly asked questions about the applicability of good laboratory practice (GLP) to non-clinical studies that are conducted to support medical device marketing applications and research1.